New RAND research identifies early predictors of cognitive impairment and dementia using a nationally representative U.S. dataset, highlighting the role of modifiable factors and baseline cognitive health in prevention and intervention strategies.
Alkermes fends off generic versions of Vivitrol until 2027 – Pharmaceutical Technology
Vivitrol is Alkermes’s highest-grossing drug and is projected to generate up to $410m in sales in 2023. Image Credit: PanuShot / Shutterstock. Alkermes has settled